While these studies support the notion that the impaired incretin effect in individuals living with T2D originates from a diminished insulinotropic action of GIP, the relative contribution of GIP to the incretin effect remains controversial and is potentially species-specific. The gene discussed is GIP; the disease is type 2 diabetes mellitus.